Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Katsuda, N.
Right arrow Articles by Tominaga, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katsuda, N.
Right arrow Articles by Tominaga, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 33:192-197 (2003)
© 2003 Foundation for Promotion of Cancer Research

Helicobacter Pylori Seropositivity and the Myeloperoxidase G-463A Polymorphism in Combination with Interleukin-1B C-31T in Japanese Health Checkup Examinees

Nobuyuki Katsuda1, Nobuyuki Hamajima2, Akiko Tamakoshi2, Kenji Wakai2, Keitaro Matsuo3, Toshiko Saito3, Kazuo Tajima3 and Suketami Tominaga4,+

1 Nagoya Kita Health Center, Nagoya, 2 Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, 3 Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi and 4 Aichi Cancer Center, Aichi, Japan

Objective: Genetic susceptibility appears to play an important role in Helicobacter pylori (HP) infection. The present study was conducted to re-examine the reported association between the myeloperoxidase (MPO) G-463A polymorphism and HP seropositivity in different subjects and to investigate interactions with smoking behavior and the interleukin-1B (IL-1B) C-31T polymorphism.

Methods: The subjects were 468 health checkup examinees in Nagoya, who consented to anonymous genotyping of residual blood samples. Genotyping was conducted by PCR-RFLP for MPO G-463A and PCR–CTPP for IL-1B C-31T.

Results: Among the successfully genotyped 437 participants without a cancer history, the HP seropositive rate was 56.2% for –463GG (n = 354), 49.4% for –463GA (n = 77) and 83.3% for –463AA (n = 6). The gender–age-adjusted odds ratio (aOR) for GA/AA relative to GG was 0.86 (95% confidence interval, 0.32–1.34) among males, 0.84 (0.47–1.49) among females, 0.83 (0.22–3.05) among current smokers and 0.87 (0.50–1.51) among never smokers. Analysis by IL-1B C-31T genotype revealed a significantly reduced OR of 0.41 (0.18–0.93) among the participants with IL-1B31CT. The OR for IL-1B31TT relative to –31CC/CT was 1.59 (1.00–2.55) among those with MPO –463GG and 3.36 (1.16–9.77) with MPO –463GA/AA. None of the gene–environment or gene–gene interactions proved to be statistically significant.

Conclusions: The association between MPO G-463A and HP seropositivity was not reproduced in this study. The effect of IL-1B –31TT was more prominent among individuals with the low expression MPO –463A allele, but it remains to be confirmed for other datasets.

+ For reprints and all correspondence: Nobuyuki Katsuda, Nagoya Kita Health Center, 4–17–1 Shimizu, Kita Ward, Nagoya 462-8522, Japan. E-mail: katsuda{at}nifty.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Goto, T. Ando, H. Goto, and N. Hamajima
No Association Between EGF Gene Polymorphism and Gastric Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2454 - 2456.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.